Filing Details
- Accession Number:
- 0001140361-21-022188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-24 16:49:05
- Reporting Period:
- 2021-06-18
- Accepted Time:
- 2021-06-24 16:49:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339005 | Femasys Inc | FEMY | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1610631 | John Dyett | C/O Femasys Inc. 3950 Johns Creek Court, Suite 100 Suwanee GA 30024 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-18 | 2,500 | $13.18 | 2,500 | No | 4 | P | Indirect | By IRA |
Common Stock | Acquisiton | 2021-06-22 | 948,342 | $0.00 | 948,342 | No | 4 | C | Indirect | By Salem Femasys Investors LLC |
Common Stock | Acquisiton | 2021-06-22 | 2,271,453 | $0.00 | 3,219,795 | No | 4 | C | Indirect | By Salem Femasys Investors LLC |
Common Stock | Acquisiton | 2021-06-18 | 10,000 | $12.88 | 10,000 | No | 4 | P | Indirect | By the Dyett Family Trust |
Common Stock | Acquisiton | 2021-06-22 | 40,000 | $13.00 | 50,000 | No | 4 | P | Indirect | By the Dyett Family Trust |
Common Stock | Acquisiton | 2021-06-22 | 63,709 | $0.00 | 113,709 | No | 4 | C | Indirect | By the Dyett Family Trust |
Common Stock | Acquisiton | 2021-06-23 | 1,000 | $9.95 | 114,709 | No | 4 | P | Indirect | By the Dyett Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By IRA |
No | 4 | C | Indirect | By Salem Femasys Investors LLC |
No | 4 | C | Indirect | By Salem Femasys Investors LLC |
No | 4 | P | Indirect | By the Dyett Family Trust |
No | 4 | P | Indirect | By the Dyett Family Trust |
No | 4 | C | Indirect | By the Dyett Family Trust |
No | 4 | P | Indirect | By the Dyett Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Convertible Preferred Stock | Disposition | 2021-06-22 | 948,342 | $0.00 | 948,342 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2021-06-22 | 2,271,453 | $0.00 | 2,271,453 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2021-06-22 | 63,709 | $0.00 | 63,709 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.
- Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein.
- 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date.
- 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date.